pioglitazone has been researched along with Heart Defects, Congenital in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
García-Beltran, C | 1 |
Cereijo, R | 1 |
Quesada-López, T | 1 |
Malpique, R | 1 |
López-Bermejo, A | 1 |
de Zegher, F | 1 |
Ibáñez, L | 1 |
Villarroya, F | 1 |
Liu, Y | 1 |
Luo, Q | 1 |
Su, Z | 1 |
Xing, J | 1 |
Wu, J | 1 |
Xiang, L | 1 |
Huang, Y | 1 |
Pan, H | 1 |
Wu, X | 1 |
Zhang, X | 1 |
Li, J | 1 |
Yan, F | 1 |
Zhang, H | 1 |
1 trial available for pioglitazone and Heart Defects, Congenital
Article | Year |
---|---|
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemo | 2020 |
1 other study available for pioglitazone and Heart Defects, Congenital
Article | Year |
---|---|
Suppression of Myocardial Hypoxia-Inducible Factor-1α Compromises Metabolic Adaptation and Impairs Cardiac Function in Patients With Cyanotic Congenital Heart Disease During Puberty.
Topics: Animals; Disease Models, Animal; Fatty Acids; Glucose; Glycolysis; Heart Defects, Congenital; Humans | 2021 |